MedMen’s Largest Investor Leads $33 Million Raise For Airgraft, A Vaporization Company
The $33 million was raised in two separate rounds
During an exclusive conversation, ahead of the publication of a press release, vaporization technology company Airgraft revealed it has closed a multi-round financing of more than $33 million, as well as the launch of a line of products including the Airgraft Clean Vaporizer, cannabis concentrate pods, and an app to control the actual vaporizer.
The $33 million were raised in two separate rounds, and most of the funds were used to develop the product line. The latest round was led by Gotham Green Partners, famed backed of MedMen Enterprises Inc (OTC: MMNFF) (CSE: MMEN) and Jane Technologies – among several others. The first round was led by HumanCo.
During this exclusive chat, HumanCo CEO and founder Jason Karp said that as someone who has dealt with autoimmune disease and heavy metals poisoning, he believes there is “a strong need for a health-focused vaping platform that provides a clean, unadulterated and trustworthy experience.
To Read The Rest Of This Article On Forbes, Click Here
